Ondansetron Basi (Ondansetron)

Ondansetron is used to manage nausea and vomiting by targeting the serotonergic pathways involved in emesis.

• Chemotherapy‑induced nausea and vomiting: helps prevent and control acute and delayed episodes.
• Radiation‑induced nausea and vomiting: reduces the frequency and severity of symptoms.
• Post‑operative nausea and vomiting: decreases the incidence of nausea after surgery.
• Hyper‑emesis gravidarum (off‑label): may be considered when conventional therapy fails.

• Ondansetron selectively blocks the 5‑hydroxy‑tryptophan (5‑HT3) receptors located on vagal afferent nerves in the gastrointestinal tract and in the chemoreceptor trigger zone of the brain. By inhibiting serotonin‑mediated signaling, it reduces the initiation of the vomiting reflex triggered by chemotherapy, radiation, or surgical stimuli.

Side effects are generally mild to moderate and vary with the route of administration.

Common Side Effects

• Headache
• Constipation
• Diarrhea
• Fatigue
• Dizziness

Serious or Rare Side Effects

• QT interval prolongation
• Severe allergic reaction (anaphylaxis)
• Serotonin syndrome
• Cardiac arrhythmias
• Hepatotoxicity

When using Ondansetron Basi, consider the following precautions to ensure safe administration.

• Cardiac monitoring: patients with known QT prolongation or electrolyte disturbances should be monitored.
• Electrolyte balance: correct hypokalemia, hypomagnesemia, or hypocalcemia before use.
• Concomitant serotonergic drugs: assess risk of serotonin syndrome.
• Pregnancy: use only if the potential benefit outweighs the risk.
• Breastfeeding: evaluate risk‑to‑infant before continuation.
• Store at ambient temperature: keep in original packaging, protect from moisture.

Ondansetron may interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Amiodarone: may increase risk of QT prolongation.
• Certain anti‑arrhythmic drugs (e.g., sotalol) that also prolong QT interval.
• Other serotonergic agents (e.g., tramadol, linezolid) that raise serotonin levels.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole) may raise ondansetron plasma levels.
• CYP3A4 inducers (e.g., rifampicin) may reduce ondase ntin efficacy.
• Antacids containing aluminum or magnesium may reduce absorption.